Dr Francesca Lim is a Senior Consultant with the Department of Haematology at the Singapore General Hospital and the Head of the Singhealth Duke NUS Cell Therapy Center.
Dr Lim specializes in Haematopoietic Stem cell Transplant and currently leads the Immune Effector Cell Therapy Clinical Programme at SGH. Dr Lim spent 2 years at MD Anderson studying under Professor Katy Rezvani, learning about CAR T therapy and the translational complexities behind these cell therapies. Upon her return to Singapore in 2019, Dr Lim help set up the IEC and CAR T cell Clinical Program at SGH. She has much clinical experience in selecting and managing patients who undergo IEC therapies especially CAR T cell therapies.
Dr Lim was appointed as Chief Medical Officer of the Singapore National GMP facility ACTRIS in 2022. She has been actively involved in many scientific discussions and has assisted in the translation of innovative cellular therapies into the clinics. As Chief Medical Officer of ACTRIS, she provides oversight and contributes to the strategic plans of the National Cell Therapy Programme and its operations.
